Ethical considerations for use of unregistered interventions for Ebola viral disease: report of an advisory panel to WHO
Author(s)
World Health OrganizationKeywords
Hemorrhagic Fever, EbolaDrug Approval
Prescription Drugs
Ethics
Disease Outbreaks
Africa, Western
Ebola Vaccines
Full record
Show full item recordOnline Access
http://www.who.int/iris/handle/10665/130997Abstract
9 p.Date
2014-08-17Type
Technical documentsIdentifier
oai:apps.who.int:10665/130997WHO/HIS/KER/GHE/14.1
http://www.who.int/iris/handle/10665/130997